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Abstract
Objective: To evaluate macular morphology in the eyes of patients with multiple sclerosis (MS) with or without optic
neuritis (ON) in previous history.
Methods: Optical coherence tomography (OCT) examination was performed in thirty-nine patients with MS and in thirty-
three healthy subjects. The raw macular OCT data were processed using OCTRIMA software. The circumpapillary retinal
nerve fiber layer (RNFL) thickness and the weighted mean thickness of the total retina and 6 intraretinal layers were
obtained for each eye. The eyes of MS patients were divided into a group of 39 ON-affected eyes, and into a group of 34
eyes with no history of ON for the statistical analyses. Receiver operating characteristic (ROC) curves were constructed to
determine which parameter can discriminate best between the non-affected group and controls.
Results: The circumpapillary RNFL thickness was significantly decreased in the non-affected eyes compared to controls
group only in the temporal quadrant (p=0.001) while it was decreased in the affected eyes of the MS patients in all
quadrants compared to the non-affected eyes (p,0.05 in each comparison). The thickness of the total retina, RNFL,
ganglion cell layer and inner plexiform layer complex (GCL+IPL) and ganglion cell complex (GCC, comprising the RNFL and
GCL+IPL) in the macula was significantly decreased in the non-affected eyes compared to controls (p,0.05 for each
comparison) and in the ON-affected eyes compared to the non-affected eyes (p,0.001 for each comparison). The largest
area under the ROC curve (0.892) was obtained for the weighted mean thickness of the GCC. The EDSS score showed the
strongest correlation with the GCL+IPL and GCC thickness (p=0.007, r=0.43 for both variables).
Conclusions: Thinning of the inner retinal layers is present in eyes of MS patients regardless of previous ON. Macular OCT
image segmentation might provide a better insight into the pathology of neuronal loss and could therefore play an
important role in the diagnosis and follow-up of patients with MS.
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Introduction
Multiple sclerosis (MS) is a chronic inflammatory disorder that
affects the central nervous system. The disease is characterized by
demyelination that leads to axonal dysfunction and neuronal loss
[1]. Unmyelinated neuronal axons offer a good possibility to
examine axonal loss as the thickness of the myelin sheath does not
affect the nerve thickness results. The innermost layer of the retina
is the retinal nerve fiber layer (RNFL) being comprised of the
axons of the retinal ganglion cells which get myelin sheath only
after leaving the eye through the lamina cribrosa. Therefore, the
thickness measurement of the RNFL might be a good marker of
the axonal damage in MS patients. Optical coherence tomography
(OCT) is a non-invasive, non-contact diagnostic tool that provides
high-resolution cross-sectional images of the retina [2]. This
technique enables, among others, the measurement of the
thickness of the RNFL around the optic disc and also the thickness
and volume of the macula lutea in vivo. With the use of OCT
image processing, not only the thickness of the total retina but also
the thickness of the intraretinal layers can be measured in the
macular area [3–5].
The loss of retinal nerve fibers around the optic disc
(circumpapillary RNFL – cpRNFL) has been found in the eyes
of MS patients both with and without optic neuritis (ON) in the
history [6–11]. However, recent studies have shown that also
macular thickness and volume are decreased in the eyes of patients
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ganglion cell layer (GCL) and inner plexiform layer (IPL) [11,15–
17].
The purpose of our study was to assess macular morphology in
patients with MS with or without ON in previous history and also
to determine which OCT parameter has the greatest ability to
detect neuronal damage in patients with MS. We could
demonstrate that the thickness of the ganglion cell complex
(GCC) is the most sensitive marker for the detection of neuronal
loss due to ON and we could also show that there are signs of
axonal degeneration even without ON in previous history. The
thickness of the GCL+IPL complex and the GCC in the macula
showed the strongest correlation with the clinical measure of
disability measured by the EDSS score.
Methods
Patient population and study design
Thirty-nine patients with relapsing-remitting multiple sclerosis
meeting the revised McDonald criteria [18] were consecutively
recruited from the Department of Neurology of Semmelweis
University between October 2008 and June 2011 in this cross-
sectional case-control study. Exclusion criteria for all patients
were: (1) spherical or cylindrical correction higher than 3.0
diopters, (2) the presence of any retinal disease or optic neuropathy
including glaucoma, except ON, (3) intraocular pressure higher
than 20 mmHg in the medical history, (4) previous eye surgery, (5)
amblyopia, (6) last ON episode less than 6 months prior to
enrollment, (7) bad fixation cooperation during the OCT
examination (e.g. due to nystagmus) and (8) low signal strength
of the OCT images (SS#6). Five eyes were excluded from the
study due to the presence of retinal disease (1 eye), acute ON (1
eye), low signal strength of the OCT image due to media opacity
(1 eye) and amblyopia (2 eyes). Thirty-three randomly selected
eyes of thirty-three age-matched controls were also examined with
OCT. The eligibility criteria for control subjects were best-
corrected Snellen visual acuity of 20/20 and the lack of any ocular
or systemic diseases. Demographic and clinical characteristics
including age, gender and duration of disease are listed in Table 1.
All participants were treated in accordance with the tenets of the
Declaration of Helsinki. Institutional Review Board approval was
obtained for all study protocols (Semmelweis University Regional
and Institutional Committee of Sciences and Research Ethics).
Written informed consent was obtained from all participants in
this study.
Ophthalmic and neurological examinations
All patients underwent an ophthalmic examination including
best-corrected Snellen visual acuity, assessment of intraocular
pressure, slit lamp biomicroscopy and binocular ophthalmoscopy
with pupil dilation. The same day, OCT examination was
performed on each eye using a Stratus OCT device (Carl Zeiss
Meditec, Dublin, CA, USA). ‘‘Fast RNFL map protocol’’
consisting of three circular scans with diameters of 3.4 mm
centered on the optic disc was performed (Fig. 1). The mean
overall and sectoral (superior, nasal, inferior and temporal)
cpRNFL thickness values were recorded for each eye. The mean
overall cpRNFL thickness was calculated by averaging the
thickness values in the four sectors. To assess the thickness of
the intraretinal layers of the macula, each eye was scanned using
the ‘‘Macular thickness map’’ protocol consisting of six evenly
spaced radial lines centered on the fovea, each having a 6 mm
transverse length (Fig. 1).
The patients underwent a comprehensive neurological exami-
nation within one week of the ophthalmic examination. To assess
physical disability, the Expanded Disability Status Scale (EDSS)
score was determined for each patient.
OCT image processing (OCTRIMA)
The raw macular OCT data were exported from the Stratus
OCT device and further processed using a computer-aided
grading methodology for OCT retinal image analysis (OC-
TRIMA) developed by Cabrera et al. [3]. The OCTRIMA
software integrates a novel denoising and edge enhancement
technique along with a segmentation algorithm. Moreover, the
software gives quantitative information of intraretinal structures
and facilitates the analysis of other retinal features that may be of
diagnostic and prognostic value, such as the morphology and
reflectivity by enabling the segmentation of the various cellular
layers of the retina [3,19]. The OCTRIMA software enables the
segmentation of 6 layers of the retina on OCT images based on
their optical densities: the RNFL, the GCL+IPL complex, the
inner nuclear layer (INL), the outer plexiform layer (OPL), the
outer nuclear layer (ONL) and retinal pigment epithelium (RPE).
We have previously shown the high repeatability and reproduc-
ibility of OCTRIMA measurements in normal subjects with
undisrupted retinal structure similarly to what is observed in
patients with MS [20,21]. The reproducibility was the highest for
the thickness measurements of the ONL, GCC, GCL+IPL and
RNFL, the inter- and intraexaminer, intervisit variabilities
(,6 mm for all layers and all comparisons) being under the
resolution of the Stratus OCT device for all layers [21]. The OCT
scan of a healthy macula before and after segmentation with
OCTRIMA can be seen on Fig. 2. It is important to note that
OCTRIMA measures the thickness of the total retina between the
inner limiting membrane and the inner boundary of the
photoreceptor outer segment/RPE junction. On the contrary,
Stratus OCT measures the thickness of the total retina between
the inner limiting membrane and the photoreceptor inner
segment-outer segment junction. We also note that the ONL is
actually enclosing the external limiting membrane and the inner
segment of the photoreceptors but in the standard 10 mm
resolution OCT image this thin membrane can not be visualized
clearly making the segmentation of the inner segment difficult.
Thus this layer classification is our assumption and does not reflect
the actual anatomic structure.
Statistical analysis
The thickness of the total retina and the intraretinal layers were
measured in the nine macular regions defined by the Early
Treatment Diabetic Retinopathy Study (ETDRS) (Fig. 1) [22].
Since the number of sampling points is different at the central
(R1), pericentral (R2–R5) and peripheral (R6–R9) regions because
Table 1. Clinical characteristics of the study patients.
Characteristic Control (n=33) MS (n=39)
Age, mean6SD, y 34.368.3 34.068.2
Age, median (range) 33 (21–52) 34 (19–53)
No. (%) female 23 (69.7) 27 (69.2)
ON-affected eye, No. (%) NA 39 (53.0)
Disease duration, mean6SD, y NA 6.563.9
Abbreviations: NA, not applicable; MS, multiple sclerosis; SD, standard
deviation.
doi:10.1371/journal.pone.0030922.t001
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OCT, a weighted mean thickness (WMT) was calculated instead
of averaging retinal thickness results in the 9 macular regions [23].
The WMT was generated using the following equation:
WMT~
R1
36
z
R2zR3zR4zR5
18
z
(R6zR7zR8zR9)x3
16
The WMT values for the RNFL, GCL+IPL, GCC, INL, OPL,
ONL, RPE and the total retina were obtained for each eye. Since
the GCC is composed by the RNFL and GCL+IPL consisting
of distal and proximal parts of the retinal ganglion cells, the
thickness of the GCC was used to describe the integrity of the
ganglion cells.
The correlation between the disease duration, age, EDSS score
and the cpRNFL and macular intraretinal thickness parameters
was calculated by linear correlation. Furthermore, the correlation
between the cpRNFL parameters and the thickness of the
intraretinal structures was also determined by linear correlation.
The eyes of the MS patients were divided into two study groups
for further analyses. The first group was composed of 39 eyes
which had ON at least 6 months prior to enrollment. All eyes in
this group had only one previous episode of ON. The second
group was composed of 34 eyes which had no history of ON. The
diagnosis of optic neuritis was based on the patient’s medical
Figure 1. Retinal scanning used in the study. The yellow arrows in the macula and the circle around the optic nerve head show the locations of
the OCT scans made. (B) The distribution of ETDRS regions for the right (OD) and left eye (OS).
doi:10.1371/journal.pone.0030922.g001
Figure 2. Macular image segmentation using OCTRIMA. The image of a healthy macula scanned by Stratus OCT. (B) The same OCT scan
processed with OCTRIMA. We note the ONL segment includes the IS of photoreceptors and the external limiting membrane, which are not resolved
by the Stratus OCT device. Abbreviations: GCL+IPL, ganglion cell layer and inner plexiform layer complex; INL, inner nuclear layer; ONL, outer nuclear
layer; OPL, outer plexiform layer; RNFL, retinal nerve fiber layer; RPE, retinal pigment epithelium.
doi:10.1371/journal.pone.0030922.g002
Retinal Neurodegeneration in Multiple Sclerosis
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30922history and defined by clinical symptoms such as decreased visual
acuity developing in few days, pain on eye movement, abnormal
response on visual evoked potential examination confirming
prechiasmal lesion and decrease in the critical flicker frequency
(CFF). CFF is a routine examination for the assessment of optic
nerve function. Particularly, in the context of optic neuritis, the
CFF is known to be decreased in the acute phase of ON and also it
can show impairment after the recovery. Therefore, measuring the
CFF can help to establish the diagnosis.
All measured thickness values were compared among the groups
using mixed model ANOVA. Receiver operating characteristic
(ROC) curves were constructed to describe the ability of each
parameter to discriminate between the eyes of MS patients not
affected with ON and the eyes of the control group.
Statistical analyses were performed using Statistica 8.0 (Statsoft
Inc., Tulsa, OK, USA) and SPSS 15.0 (SPSS Inc., Chicago, IL,
USA). A p value of ,0.05 was considered statistically significant.
Results
All eyes had a Snellen visual acuity of 1.0. The strongest
correlation was observed between the EDSS and the GCL+IPL,
GCC and mean overall cpRNFL (p=0.007, p=0.007 and
p=0.008, respectively; r=20.43 for all variables) while the
correlations with the inferior cpRNFL, superior cpRNFL and the
WMT of the RNFL in the macula was weaker (p=0.02, p=0.05
and p=0.05, respectively; r=20.38, r=20.33 and r=20.32,
respectively). The remaining intraretinal layers and cpRNFL
parameters showed no correlation with the EDSS. There was no
correlation between any of the thickness values measured and
either disease duration or age.
The mean overall cpRNFL thickness and the cpRNFL thickness
in the superior, nasal, inferior and temporal quadrants was
significantly decreased in the eyes of MS patients previously
affected with ON compared to the non-affected eyes of MS
patients (see Table 2). Each cpRNFL thickness parameter was
significantly lower in the ON-affected eyes compared to controls
except for the cpRNFL thickness in the nasal quadrant. However,
the eyes not affected with ON showed significantly lower cpRNFL
thickness values compared to the control group only in the
temporal quadrant. The cpRNFL was thinner in the superior,
nasal, inferior and temporal quadrants by 16%, 11%, 16% and
27%, respectively in the ON-affected eyes compared to controls
and by 6%, 4%, 4% and 17%, respectively in the eyes without ON
in medical history compared to controls.
The WMT of the total retina, RNFL, GCL+IPL and GCC
showed a significant decrease in both the ON-affected and non-
affected eyes of MS patients compared to the control group
(Table 2). Furthermore, the eyes previously affected with ON had
significantly lower thickness values in these layers than the eyes not
affected with ON. There was no statistically significant difference
in any of the remaining intraretinal layers among the groups.
The strongest correlation was observed between the mean
overall cpRNFL thickness and the thickness of the GCL+IPL and
GCC in the macula (r=0.76 and r=0.75, respectively) while the
correlation was weaker in the case of the total retina in the macula
(r=0.68). An average 10 mm loss of the average cpRNFL thickness
was associated with 7.5 mm reduction in the total retinal thickness
and also a 7.5 mm reduction in the thickness of the GCC, the latter
resulting from a 5.3 mm reduction of the GCL+IPL and a 2.2 mm
reduction of the RNFL.
The thickness of the RNFL in the macula was significantly
decreased in the non-affected eyes of MS patients compared to the
healthy eyes in the inner inferior (R4), inner temporal (R5), outer
superior (R6) and outer nasal (R7) regions (see Table 3 and
Figure 3). In the eyes affected with ON, macular RNFL thickness
was significantly lower in each region compared to the control
group and it was also lower compared to the eyes not affected with
ON in each region except for the outer temporal region (R9). The
thinning of the GCL+IPL was observed in each ETDRS region in
the non-affected eyes of MS patients compared to controls and in
the ON-affected eyes of MS patients compared to both healthy
Table 2. WMT values of the intraretinal layers and the total retina in the study groups.
Thickness, mm, mean±SD p values
Intraretinal layer Control (33 eyes) NE group (34 eyes) AE group (39 eyes) NE vs. Control AE vs. Control NE vs. AE
RNFL 38633 4 633 1 65 0.001* ,0.001* ,0.001*
GCL+IPL 72646 3 665 4 67 ,0.001* ,0.001* ,0.001*
GCC 109669 8 688 5 612 ,0.001* ,0.001* ,0.001*
INL 33623 4 623 3 62 0.541 0.740 0.622
OPL 32623 2 623 2 62 0.612 0.721 0.210
ONL 79658 1 678 1 66 0.196 0.087 0.396
RPE 12611 2 611 2 61 0.950 0.589 0.390
Total Retina 290682 8 3 611 268614 0.013* ,0.001* ,0.001*
cpRNFL sector
Mean Overall 103679 4 619 85614 0.101 ,0.001* 0.037*
Superior 131610 122621 110619 0.051 ,0.001* 0.001*
Nasal 77613 81621 69617 0.328 0.066 0.002*
Inferior 130616 124618 109621 0.141 ,0.001* ,0.001*
Temporal 73613 61612 53613 0.001* ,0.001* 0.002*
*statistically significant.
Abbreviations: SD=standard deviation; NE=non-affected eye; AE=affected eye; RNFL=retinal nerve fiber layer; GCL+IPL=ganglion cell layer and inner plexiform layer
complex; GCC=ganglion cell complex; INL=inner nuclear layer; OPL=outer plexiform layer; ONL=outer nuclear layer; RPE=retinal pigment epithelium.
doi:10.1371/journal.pone.0030922.t002
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significantly lower in each region in the non-affected eyes of MS
patients compared to the control group and in the ON-affected
eyes compared to both the control group and the non-affected eyes
(Table 3 and Figure 3). The thickness of the total retina was
significantly thinner in each region except for the central region
Table 3. Regional differences in the thickness of the intraretinal layers in the groups which showed statistically significant
difference.
Thickness, mm, mean±SD p values
Control (33 eyes) NE group (34 eyes) AE group (39 eyes) NE vs. Control AE vs. Control NE vs. AE
RNFL
R1 NL NL NL NA NA NA
R2 27642 6 642 3 65 0.172 ,0.001* 0.002*
R3 24642 3 641 9 66 0.291 ,0.001* ,0.001*
R4 30642 5 642 1 66 ,0.001* ,0.001* 0.001*
R5 19651 5 641 3 65 0.001* ,0.001* 0.027*
R6 51654 6 644 1 65 ,0.001* ,0.001* ,0.001*
R7 53664 7 644 2 67 0.001* ,0.001* ,0.001*
R8 40633 8 623 5 67 0.107 ,0.001* 0.001*
R9 28642 5 642 3 66 0.051 ,0.001* 0.091
GCL+IPL
R1 NL NL NL
R2 96668 7 697 2 611 ,0.001* ,0.001* ,0.001*
R3 95668 7 611 71610 ,0.001* ,0.001* ,0.001*
R4 94658 4 687 2 69 ,0.001* ,0.001* ,0.001*
R5 95658 5 687 3 610 ,0.001* ,0.001* ,0.001*
R6 67655 7 684 9 69 ,0.001* ,0.001* ,0.001*
R7 72666 1 695 2 610 ,0.001* ,0.001* ,0.001*
R8 61655 4 654 7 67 ,0.001* ,0.001* ,0.001*
R9 69666 3 665 4 67 0.001* ,0.001* ,0.001*
GCC
R1 NL NL NL
R2 124681 1 2 611 95614 ,0.001* ,0.001* ,0.001*
R3 120681 0 9 612 90615 0.001* ,0.001* ,0.001*
R4 124661 0 9 611 93614 ,0.001* ,0.001* ,0.001*
R5 113661 0 0 611 86613 ,0.001* ,0.001* ,0.001*
R6 117681 0 3 699 1 613 ,0.001* ,0.001* ,0.001*
R7 125681 0 9 610 93615 ,0.001* ,0.001* ,0.001*
R8 101669 2 678 2 611 ,0.001* ,0.001* ,0.001*
R9 97678 9 677 8 610 ,0.001* ,0.001* ,0.001*
Total retina
R1 234617 237620 226614 0.773 0.171 ,0.001*
R2 324613 319612 299616 0.115 ,0.001* ,0.001*
R3 322613 318614 298617 0.231 ,0.001* ,0.001*
R4 322611 312610 295615 0.001* ,0.001* ,0.001*
R5 312612 302611 288614 0.002* ,0.001* ,0.001*
R6 293682 8 3 613 268616 0.006* ,0.001* ,0.001*
R7 301610 290614 272618 0.006* ,0.001* ,0.001*
R8 271672 6 7 612 254614 0.103 ,0.001* ,0.001*
R9 271610 265613 253612 0.080 ,0.001* ,0.001*
For the distribution of the ETDRS regions see Figure 1.
*statistically significant.
Abbreviations: SD=standard deviation; NE=non-affected eye; AE=affected eye; NL=no layer; NA=not applicable; RNFL=retinal nerve fiber layer; GCL+IPL=ganglion
cell layer and inner plexiform layer complex; GCC=ganglion cell complex; INL=inner nuclear layer; OPL=outer plexiform layer; ONL=outer nuclear layer; RPE=retinal
pigment epithelium.
doi:10.1371/journal.pone.0030922.t003
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healthy eyes while it was thinner in each region in the affected eyes
compared to the non-affected. For the comparison of the eyes of
MS patients not affected with ON versus healthy subjects’ eyes
there was a significant thinning only in the inner inferior (R4),
inner temporal (R5), outer superior (R6) and outer nasal (R7)
regions (see Table 3 and Figure 3).
The largest area under the curve (AUC) value for the
discrimination between the non-affected eyes of MS patients and
the eyes of the control group was obtained for the WMT of the
GCC (0.892) (see Table 4). The AUC values for the thickness data
obtained by the built-in software of the Stratus OCT – namely the
cpRNFL thickness in the temporal quadrant and the thickness of
the total retina – were below that of the GCC, 0.745 and 0.709,
respectively. Within the GCC, the largest AUC was obtained for
the inner temporal and outer nasal regions (R5 and R7,
respectively) (0.867 and 0.851) for the discrimination between
non-affected eyes of MS patients and controls (see Table 4).
Discussion
This study evaluated the usefulness of macular OCT image
segmentation in patients with MS in order to determine the
structural changes of the retina of MS patients. Furthermore, the
parameter which could discriminate best the eyes of healthy
subjects from the eyes of MS patients was determined.
Objective markers might be necessary not only for the diagnosis
but also the follow-up of neuronal damage in MS, which could
help to determine the effect of any possible therapeutical
interventions in the future as well. Our results showed that the
thickness of the macular ganglion cell complex had the highest
sensitivity and specificity to detect axonal loss independent of optic
neuritis, outperforming the cpRNFL thickness data provided by
the analysis software of the commercially available Stratus OCT
device. A strong correlation with disease severity measured by the
EDSS score was also obtained in the case of the GCC thickness
which implies that this parameter might also be useful in the
estimation of disease progression as a surrogate marker. Indeed,
Syc et al. have used a similar segmentation methodology to ours
extracting four retinal layers (after collapsing the INL+OPL layers)
in their recent report and found that the thickness of the
GCL+IPL could be a valuable parameter for the longitudinal
follow-up of neuronal loss after optic neuritis [17]. Our study has
also shown that optic neuritis is followed by a targeted loss of
ganglion cells in the macula which can also be objectively assessed
by quantitative analysis of OCT macular images.
Several studies have reported the atrophy of the RNFL around
the optic disc in patients with MS with and even without optic
neuritis in medical history [6–11]. Our findings confirmed that the
mean overall cpRNFL thickness and the cpRNFL thickness in
each quadrant is significantly lower in the eyes of MS patients with
a history of ON compared to the non-ON-affected eyes and also in
comparison with healthy eyes except for the nasal quadrant.
However, our results showed that in the non-affected eyes of MS
patients the cpRNFL thickness is decreased only in the temporal
quadrant compared to healthy eyes. Furthermore, the most
pronounced reduction in the thickness of cpRNFL (27% and
17% in the ON-affected and non-affected eyes, respectively) was
also observed in the temporal quadrant. These findings are in
agreement with previous OCT studies confirming that the fibers of
the papillomacular bundle are the most susceptible to damage in
ON [9,24]. One important aspect of this fact, as it has been widely
reported in glaucomatous damage, is that the evaluation of the
sectoral thickness values could provide the possibility to discrim-
inate the RNFL atrophy caused by glaucomatous damage and
other disorders affecting the optic nerve, such as MS [6].
As a result of neuronal loss, not only the thickness of the
cpRNFL is decreased but also the macula was found to be thinner
in the eyes of MS patients in previous reports [6,7,12–14].
Histopathological studies had qualitatively shown the atrophy of
the inner retina in the eyes of MS patients, while atrophy of the
outer nuclear layer was not detected [25,26]. However, no
quantitative measurements were performed because of technical
difficulties, e.g. the partial post-mortem detachment occurring in
the retina in many of the eyes. Lately, some studies evaluating a
low number of patients and using OCT technology showed that
the thickness of the inner retinal layers is decreased in the eyes of
MS patients [11,15–17]. However, the reliability of the method-
ologies used in these studies is not known. Burkholder et al.
analyzed a large sample consisting of 530 subjects with RRSM,
assessing the volume of the total retina in the inner and outer
ETDRS rings (also referred to as pericentral and peripheral
macular rings). Their results showed the thinning of the inner and
outer retinal ETDRS rings in the eyes of MS patients; however,
the local morphological changes of the observed thinning could
not be identified as they did not use any segmentation
methodology. The OCT image segmentation methodology used
in our study allowed the quantification of local retinal changes in
patients with MS in vivo. Our results confirmed that the atrophy
of the RNFL, GCL+IPL and consequently the GCC is present in
the macula of patients with MS even in eyes without ON in
previous history. Furthermore, we demonstrated that the outer
Figure 3. Regional differences between the non-affected eyes of MS patients and healthy eyes. The colors show the extent of thinning
based on the p-values of the thickness comparisons. All representative numerical data are in Table 3. The color codes are as follows: red: p,0.001,
yellow: 0.001,p,0.05, green: p.0.05. We note the central subfield (R1: black color) was excluded from the analysis for the layers which are not
present in the foveal area. Abbreviations: GCC, ganglion cell complex; GCL+IPL, ganglion cell layer and inner plexiform layer complex; RNFL, retinal
nerve fiber layer; TR, total retina.
doi:10.1371/journal.pone.0030922.g003
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not an inclusion criterion, all patients had only one episode of ON
in the history; therefore, the observed changes were not biased by
the number of ON episodes. The thinning of the retina was most
pronounced in the inner inferior, inner temporal, outer superior
and outer nasal regions.
The average cpRNFL thickness showed the strongest correla-
tion with the thickness of the GCL+IPL and GCC in the macula
while a weaker correlation was observed with the thickness of the
total retina. Previous studies have also shown that there is a
correlation between the mean overall cpRNFL thickness and the
thickness of the total retina in the macula, the correlation
coefficient in the study of Fjeldstad et al. was the same as in our
results (r=0.68) [7]. In the study of Burkholder et al., 10 mm
reduction in the mean overall cpRNFL thickness was associated
with a 0.2 mm
3 reduction of the total macular volume [13]. As the
area of the macula – which is imaged using Stratus OCT – is
approximately 28.26 mm
2, the volume of 0.2 mm
3 consequently
equals to about 7.1 mm in thickness. Our results have shown a
similar amount of reduction (7.5 mm) in the total retinal thickness
which was accounted for by the reduction of the GCC thickness.
Previously, the mean overall cpRNFL thickness was found to
correlate significantly with functional parameters such as EDSS
score and contrast sensitivity [27–29]. However, the thickness of
the GCL+IPL in the macula was found to correlate better with
these functional parameters, which might thus be a better marker
of axonal damage [16]. Our results showed good correlation
between the EDSS score and the mean overall cpRNFL thickness
and also the thickness of the GCL+IPL and the GCC in the
macula. However, the ROC analysis revealed that the value most
capable of determining the presence of neuronal damage was the
weighted mean thickness of the GCC having an AUC value of
0.892 with a cutoff value of 104 mm having the highest sensitivity
and specificity. The thickness of the RNFL and GCL+IPL
separately showed lower AUCs than the GCC which could be
explained with the better reproducibility of the GCC due to the
high contrast between the IPL and INL layers. Furthermore, the
AUC values observed for the parameters which can be measured
using conventional OCT softwares (i.e. the temporal cpRNFL
thickness and the average thickness of the total retina expressed as
macular volume) were much lower compared to that of the GCC.
Despite their lower AUC values we believe these parameters may
still be of clinical importance due to their widespread access by all
OCT devices. Among the regional thickness values, the thickness
of the GCC in the inner temporal region was observed to have the
largest AUC value, namely 0.867 (see Table 4).
Although our results showed that the weighted mean GCC
thickness may provide a sensitive tool for the assessment of axonal
degeneration, care should be taken when interpreting its value as
numerous neurodegenerative disorders, such as glaucoma [30–34],
Alzheimer’s disease [35,36] or Parkinson’s disease [37–39] may also
lead to ganglion cell death. The use of regional valuescould help the
differential diagnosis between various forms of neurodegeneration,
as glaucoma could presumably lead to an infero-superior pattern of
GCC loss in the macula, while according to our results MS is rather
leading to a horizontal loss of the GCC most probably due to the
loss of the papillo-macular nerve bundle. However, further research
is warranted to justify the above hypothesis.
A potential limitation of the study is the relatively low number of
MS patients included. Although the size of our study is in
accordance with previous similar reports, a larger set of patients
may be desired to obtain information with even higher power.
Another weakness might be the time-domain OCT technology
used which could both limit the accuracy of our measurements due
to lower resolution when compared with spectral-domain OCT
technology which facilitates wider and finer sampling of the
macular regions. However, we have previously shown the high
reliability and reproducibility of OCTRIMA measurements
Table 4. Results of the ROC analysis for the WMT thickness variables which showed significant difference between the eyes not
affected with ON and controls and for the regional GCC thickness values.
Variable AUC Asymptotic 95% CI Cutoff point Sensitivity Specificity
Lower bound Upper bound (mm)
WMT values of the intraretinal layers
GCC 0.892 0.818 0.966 104 76% 74%
GCL+IPL 0.869 0.785 0.952 68 79% 77%
RNFL 0.809 0.707 0.911 35 82% 56%
Temporal cpRNFL 0.745 0.628 0.861 67 73% 68%
Total Retina 0.709 0.585 0.834 288 73% 62%
Regional thickness values for the GCC
R2 (inner superior) 0.792 0.683 0.902 91 85% 62%
R3 (inner nasal) 0.740 0.616 0.863 91 76% 65%
R4 (inner inferior) 0.845 0.751 0.938 91 79% 77%
R5 (inner temporal) 0.867 0.778 0.957 90 82% 74%
R6 (outer superior) 0.839 0.747 0.931 63 76% 74%
R7 (outer nasal) 0.851 0.764 0.939 65 88% 65%
R8 (outer inferior) 0.820 0.720 0.920 57 79% 62%
R9 (outer temporal) 0.731 0.612 0.850 65 64% 59%
Note that the central region for the GCC is missing due to the partial lack of ganglion cells in the foveola.
Abbreviations: AUC=area under the curve; CI=confidence interval; GCC=ganglion cell complex; GCL+IPL=ganglion cell layer and inner plexiform layer complex;
RNFL=retinal nerve fiber layer, cpRNFL=circumpapillary RNFL.
doi:10.1371/journal.pone.0030922.t004
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bility with higher resolution Fourier-domain OCT measurements
[40].
Our results imply that mainly the ganglion cells are affected in
MS and changes can be already present in eyes without previous
history of ON which could be the result of axonal loss due to the
disease process of MS or mild optic neuritis events not
accompanied by pain. By the use of OCT image segmentation,
we could also show in vivo that the neuronal damage affects the
ganglion cells and not the outer retina, while episodes of ON are
resulting in a further pronounced loss of the retinal ganglion cells.
Furthermore, our measurements obtained with a custom-built
software were shown to be more sensitive compared to standard
measurements extracted by the Stratus OCT device (e.g. cpRNFL,
total macular volume) and also showed a stronger correlation with
physical disability measured by the EDSS. This implies the
potential clinical usefulness of the quantification of the macular
GCC thickness by OCT image segmentation, which could also
facilitate the cost-effective follow-up of neuronal damage due to
MS.
In conclusion, we consider that macular OCT image segmen-
tation showing in vivo structural changes of retinal tissue will yield
a better insight into macular pathology and therefore should play
an important role in the future of the diagnosis and follow-up of
neurological diseases affecting the optic nerve, such as multiple
sclerosis which influences a continuously increasing number of
patients worldwide.
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